Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DEBORAH KNOBELMAN Insider Profile
4 Followers
DEBORAH KNOBELMAN, CFO, Head of Corporate Development at Senti Biosciences, holds 164.26K shares in Kronos Bio (Ticker: KRON), holds 131.00K shares in Senti Biosciences (Ticker: SNTI).
DEBORAH KNOBELMAN has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that DEBORAH KNOBELMAN holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by DEBORAH KNOBELMAN
DEBORAH KNOBELMAN's Trading History
Senti Biosciences
Feb 02, 2024
CFO, Head of Corporate Development
Uninformative Buy
―
$520.07K
Kronos Bio
Jun 04, 2024
Chief Financial Officer
Uninformative Buy
―
$157.20K
List of latest transactions for each holding click on a transaction to see DEBORAH KNOBELMAN's performance on stock
You May Also Like
DEBORAH KNOBELMAN insider profile FAQ
What is the percentage of profitable transactions made by DEBORAH KNOBELMAN?
The percentage of profitable transactions made by DEBORAH KNOBELMAN is ―.
What is the average return per transaction made by DEBORAH KNOBELMAN?
The average return per transaction made by DEBORAH KNOBELMAN is ―.
What stocks does DEBORAH KNOBELMAN hold?
DEBORAH KNOBELMAN holds: SNTI, KRON stocks.
What was DEBORAH KNOBELMAN’s latest transaction?
DEBORAH KNOBELMAN latest transaction was an Uninformative Buy of ―.
What was DEBORAH KNOBELMAN's most profitable transaction?
DEBORAH KNOBELMAN’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is DEBORAH KNOBELMAN's role in Senti Biosciences?
DEBORAH KNOBELMAN's role in Senti Biosciences is CFO, Head of Corporate Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.